Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Operating Expenses (2020 - 2025)

iSpecimen has reported Operating Expenses over the past 6 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 358.89% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $17.4 million, up 29.27%, while the annual FY2025 figure was $10.9 million, 94.93% up from the prior year.
  • Operating Expenses for Q4 2025 was $9.2 million at iSpecimen, up from $2.9 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $9.2 million in Q4 2025 and troughed at -$9.8 million in Q4 2023.
  • A 5-year average of $3.7 million and a median of $4.5 million in 2021 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: crashed 291.93% in 2023 and later soared 358.89% in 2025.
  • Year by year, Operating Expenses stood at $4.5 million in 2021, then grew by 12.3% to $5.1 million in 2022, then crashed by 291.93% to -$9.8 million in 2023, then soared by 120.46% to $2.0 million in 2024, then soared by 358.89% to $9.2 million in 2025.
  • Business Quant data shows Operating Expenses for ISPC at $9.2 million in Q4 2025, $2.9 million in Q3 2025, and $2.5 million in Q2 2025.